• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

nclemons@unimelb.edu.au

Credentials


Position
Casual
Department of Clinical Pathology
Education
PhD
University of Melbourne
Bachelors Degree
University of Tasmania
Bachelors Degree (Honours)
University of Tasmania
ORCID

0000-0001-9283-9978

A/Prof Nicholas Clemons

Honorary (Principal Fellow)
The Sir Peter MacCallum Department of Oncology

103 Scholarly works
10 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Peritoneal tumour DNA—A promising peritoneal-specific biomarker for diagnosis, prognosis, and monitoring treatment response
    DOI: 10.1002/ijc.70334
  • 2026

    Journal article

    Abstract 601: Translational reprogramming disrupts mitosis to drive SMAD4-deficient esophageal adenocarcinoma.
    DOI: 10.1158/1538-7445.am2026-601
  • 2025

    Journal article

    Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines
    DOI: 10.1038/s42003-025-08251-0
  • 2025

    Journal article

    Role of Neoadjuvant Immune Checkpoint Inhibitors in Locally Advanced Rectal Cancer: A Systematic Review of Currently Available Studies
    DOI: 10.1097/DCR.0000000000003927
  • 2023

    Research grants (ARC, NHMRC, MRFF)

    Improving Therapeutic Responses in Oesophageal Cancer by Overcoming Resistance to Ferroptosis
  • 2020

    Research Grant

    Establishing the Functional Genetic Drivers of Oesophageal Adenocarcinoma
  • 2017

    Research Grant

    A New Paradigm for Targeting Mutant P53 Tumours
Nicholas Clemons

Latest Honours,
Awards and Fellowships


2000
Melbourne Research Scholarship
1996
National Undergraduate Scholarship University of Tasmania

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    091. MULTI-OMICS EVALUATION OF PERITONEAL FLUID IN GASTROESOPHAGEAL CANCER: RESULTS FROM INTERIM ANALYSIS
    DOI: 10.1093/dote/doaf061.006
  • 2025

    Journal article

    Neoadjuvant intraperitoneal chemotherapy in high-risk and cytology positive gastric cancer: a systematic review
    DOI: 10.1016/j.suronc.2025.102237
  • 2025

    Journal article

    Circulating tumor DNA (ctDNA) analysis for improved treatment response assessment and prediction of clinical outcomes in patients with esophageal cancer.
    DOI: 10.1200/jco.2025.43.16_suppl.4077
  • 2025

    Journal article

    Abstract 4065: Unveiling drivers of esophageal adenocarcinoma with CRISPR pooled screen and single-cell RNA-sequencing
    DOI: 10.1158/1538-7445.am2025-4065
  • 2025

    Journal article

    Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment
    DOI: 10.1371/journal.pone.0318615
  • 2025

    Journal article

    Commentary on Liquid Biopsy Detection of a TP53 Variant in a “Disease-Free” Pediatric Patient with a History of TP53-mutant Adrenocortical Carcinoma
    DOI: 10.1093/clinchem/hvae132

RECENT PROJECTS

  • 2023

    Research grants (ARC, NHMRC, MRFF)

    Gene Modified Pluripotent Stem Cells to Generate and Empower Innate Immune Cells Against Poor\2010prognosis Cancers
  • 2024

    Research grants (other domestic)

    Finding and Understanding the Optimal Treatment for Gastroesophageal Cancers

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224